Sidharaj Pharma (Thane) Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.40 M
- Company Age 39 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.94 M
- Revenue Growth -88.98%
- Profit Growth -90.99%
- Ebitda -96.29%
- Net Worth 4.43%
- Total Assets 1.81%
About Sidharaj Pharma (Thane)
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1985PTC037192
-
Company No.
037192
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Aug 1985
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sidharaj Pharma (Thane)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubhangi Apte
|
Managing Director | 09-Jun-1994 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Santosh Bhide
|
Director | 25-Apr-1994 | Current |
|
Anand Apte
|
Director | 25-Apr-1994 | Current |
|
Pradnya Bhide
|
Director | 01-Dec-2001 | Current |
Financial Performance of Sidharaj Pharma (Thane).
Sidharaj Pharma (Thane) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 88.98% decrease. The company also saw a substantial fall in profitability, with a 90.99% decrease in profit. The company's net worth moved up by a moderate rise of 4.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sidharaj Pharma (Thane)?
In 2019, Sidharaj Pharma (Thane) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Goldfinch Engineering Systems Private LimitedSantosh Bhide, Shubhangi Apte and 2 more are mutual person
-
Goldfinch Evaporation Systems Private LimitedSantosh Bhide, Shubhangi Apte and 2 more are mutual person
Charges (Loans)
₹0
₹6.94 M
Charges Breakdown by Lending Institutions
- The Thane Janata Sahakari Bank Lt.D : 0.69 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2003 | The Thane Janata Sahakari Bank Lt.D | ₹1.87 M | Satisfied |
| 31 Mar 2001 | The Thane Janata Sahakari Bank Lt.D | ₹2.50 M | Satisfied |
| 06 Nov 1998 | The Thane Janata Sahakari Bank Lt.D | ₹0.45 M | Satisfied |
| 08 Dec 1995 | The Thane Janata Sahakari Bank Lt.D | ₹1.50 M | Satisfied |
| 02 Aug 1988 | The Thane Janata Sahakari Bank Lt.D | ₹0.42 M | Satisfied |
How Many Employees Work at Sidharaj Pharma (Thane)?
Unlock and access historical data on people associated with Sidharaj Pharma (Thane), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sidharaj Pharma (Thane), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sidharaj Pharma (Thane)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
